Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Goldnboy1on Mar 16, 2021 5:23pm
352 Views
Post# 32810274

Next big thing.

Next big thing.

Hey guys. Full disclosure. Just a retail like all of you. 

Wont come here cross spamming often. Love this company. 

Back in December 2020 I did a year end review of all biotechs on the TSX. Oncolytics was high on my list! 

But it wasn't at the top because one stock on the TSX had so much realistic upside. 

That stock is Advanced Proteome Therapeutics. 

This company crashed hard in 2019 due to their founder and intellectual capital passing away. 

Stock was rolled back and invention shares erased. Nice and tight as the company moves to licensing and human trials phases on their current and near future inventions. 


$APC.v. It's starting to break out. Incoming ceo. Tufts/Columbia educated doctor who has literally spent the past six years researching failed patents that can be revived with his current and future patents. 

Get long there. Easy short term (less than a year) 5x+ coming and then some in 2022!!

FYI. In 2020. I called the #1 and #2 mining stocks based on annual ROI ($bz.v and $ora.t). This is my 2021 whale. Trust me when I say this. It's gonna be a big one!

GLTA! 

<< Previous
Bullboard Posts
Next >>